Mirum Pharmaceuticals (MIRM) PT Raised to $126 at Evercore ISI
Tweet Send to a Friend
Evercore ISI analyst Gavin Clark-Gartner raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $126.00 (from $101.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
